Insider Trading June 16, 2026 05:26 PM

IES Holdings Director Todd Sells $3.8M in Stock Amid Strong Run

Executive Chairman Gendell Also Sold Shares Earlier This Month as Company Reports Q2 Growth

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
IESC

IES Holdings director Cleveland Todd sold 5,000 shares worth $3.81 million on June 12, 2026, following a 169% stock surge over the past year. The company recently reported Q2 fiscal 2026 growth in non-residential markets, including data centers and electrical infrastructure, while facing renewed insider selling activity.

IES Holdings Director Todd Sells $3.8M in Stock Amid Strong Run
IESC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • IES Holdings director Cleveland Todd sold 5,000 shares for $3.81 million on June 12, 2026, after the stock surged 169% over the past year.
  • Executive Chairman Jeffrey L. Gendell and affiliates previously sold 32,365 shares between May 26-27, 2026, at prices between $702.24 and $710.37.
  • IES Holdings reported Q2 fiscal 2026 growth in non-residential markets including data centers and electrical infrastructure, prompting Freedom Broker to upgrade its price target to $700 while downgrading its rating to "hold".

IES Holdings, Inc. (NASDAQ:IESC) saw significant insider activity as director Cleveland Todd M. executed a substantial sale of company shares on June 12, 2026. The transaction involved the disposal of 5,000 shares of common stock, generating proceeds of approximately $3.81 million. The shares were sold at prices ranging from $760.41 to $763.35, reflecting the elevated valuation levels the stock has reached.

Todd's sale was structured across multiple transactions on the same day. The director sold 1,100 shares at a weighted average price of $760.41 per share, followed by 1,200 shares at $761.31 per share, another 1,200 shares at $762.01 per share, and a final block of 1,500 shares at $763.35 per share. Following this transaction, Todd directly holds 60,874 shares of IES Holdings common stock.

The insider sale comes during a period of exceptional stock performance for IES Holdings. The company's shares have delivered a 169% return over the past year and gained 62% in the last six months. The stock currently trades at a P/E ratio of 37.47 with a market capitalization of $13.89 billion. According to InvestingPro analysis, IESC appears overvalued at current levels, with 15 additional ProTips available to subscribers.

Beyond Todd's transaction, IES Holdings has experienced broader insider selling activity. Executive Chairman Jeffrey L. Gendell and affiliated entities sold 32,365 shares of common stock on May 26 and May 27, 2026. These sales were executed at prices between $702.24 and $710.37 per share. The concentration of insider transactions has drawn attention from investors and market analysts monitoring the company's leadership positions.

In recent corporate developments, IES Holdings reported significant progress in its second quarter of fiscal 2026. The company documented growth in non-residential markets, particularly within data centers, electrical infrastructure, and engineered solutions. This performance prompted Freedom Broker to adjust its rating on IES Holdings from a "buy" to a "hold," although the firm raised its price target to $700.

The combination of strong operational performance and substantial insider selling creates a complex signal for market participants. While the company demonstrates growth in key infrastructure sectors, the pattern of executive transactions warrants careful consideration alongside valuation metrics.

Risks

  • The stock's 169% annual return and 37.47 P/E ratio suggest potential overvaluation concerns that could impact investor sentiment.
  • Concentrated insider selling by both directors and executive leadership may signal caution regarding current valuation levels.
  • The downgrade from "buy" to "hold" by Freedom Broker reflects shifting analyst perspectives despite raised price targets.

More from Insider Trading

Globe Life Executive Dolores Skarjune Executes $693K Stock Sale Following Strong Rally Jun 16, 2026 Gilead Sciences Executive Disposes of $371K in Shares Amid HIV Drug Pipeline Progress Jun 16, 2026 Ra Capital Management Cuts Werewolf Therapeutics Holding by $173,757 Jun 16, 2026 Amprius Technologies Director Offloads $1.46M in Shares Amid Market Volatility and Corporate Developments Jun 16, 2026 Venture Global's General Counsel Offloads $12.8M in Shares Amid Market Shifts Jun 16, 2026